HLX3902

· Shanghai Henlius Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HLX3902, covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours [Phase 1]